Home Supplements How We Rate Blog
Urolithin A

Urolithin A

Research reviewed: Up until 03/2026

Urolithin A is a dietary supplement with 7 published peer-reviewed studies involving 362 participants, researched for Mitochondrial Health & Muscle, Anti-inflammatory & Longevity, Exercise Performance and 1 more areas.

7
Studies
362
Participants
2019–2023
Research Span

Evidence at a Glance

Strength is scored by study design, sample size, study type, and outcomes

Overall: Strong Evidence

Mitochondrial Health & Muscle

Strong
2 studies 2 of 2 positive 154 participants

Anti-inflammatory & Longevity

Moderate
2 studies 1 of 2 positive 160 participants

Exercise Performance

Moderate
2 studies 1 of 2 positive 48 participants 1 human

Muscle Performance & Aging

Strong
1 study 1 of 1 positive 3,464,500 participants

Research Visualised

Visual breakdown of the clinical data.

Study Quality Breakdown

What types of studies were conducted

6/7
Randomised
4/7
Double-Blind
5/7
Placebo-Controlled

Participants Per Study

Larger samples = more reliable results

Study 1 (2019)
66
Study 2 (2022)
88
Study 3 (2021)
60
Study 4 (2019)
100
Study 5 (2023)
48
Study 6 (2023)
0
Study 7 (2022)
3,464,500

Research Timeline

When the studies were published

2
2019
1
2021
2
2022
2
2023

All Studies

Detailed breakdown of each trial. Click to expand.

Mitochondrial Health & Muscle

1

To evaluate Urolithin A on mitochondrial function and muscle endurance in older adults

2019 66 participants 4 months 500-1000 mg/day Urolithin A
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate Urolithin A on mitochondrial function and muscle endurance in older adults

Dose

500-1000 mg/day Urolithin A

Participants

66 adults over age 60

Duration

4 months

Results

Significant improvement in mitochondrial gene expression and function. 6-minute walk distance increased by 9.7% vs 1.1% placebo. Muscle endurance significantly improved. First human urolithin A trial.

How They Measured It

Mitochondrial biogenesis markers, 6-minute walk, grip strength, hand dynamometry

Read full study
2

To assess Urolithin A on muscle strength and function in older adults

2022 88 participants 24 weeks 1000 mg/day Urolithin A
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To assess Urolithin A on muscle strength and function in older adults

Dose

1000 mg/day Urolithin A

Participants

88 older adults (65-90 years)

Duration

24 weeks

Results

Significant improvement in leg muscle strength (p=0.03) and performance. Mitophagy and mitochondrial biogenesis markers improved. Physical function scores increased vs placebo.

How They Measured It

Leg muscle strength, handgrip, 6-MWT, mitochondrial markers

Read full study

Anti-inflammatory & Longevity

3

To evaluate Urolithin A on inflammatory biomarkers and metabolic health

2021 60 participants 12 weeks 500 mg/day Urolithin A
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate Urolithin A on inflammatory biomarkers and metabolic health

Dose

500 mg/day Urolithin A

Participants

60 healthy middle-aged adults

Duration

12 weeks

Results

Significant reductions in CRP (p=0.04) and IL-6. Mitochondrial function biomarkers improved. Metabolic pathways associated with healthy aging activated. Good tolerability.

How They Measured It

CRP, IL-6, TNF-alpha, metabolomics, mitochondrial markers

Read full study
4

To assess bioavailability and safety of Urolithin A in healthy adults

2019 100 participants 28 days 250-2000 mg Urolithin A single and repeated dose
Human Study RCT Mixed

Study Type

Randomised, pharmacokinetic study

Purpose

To assess bioavailability and safety of Urolithin A in healthy adults

Dose

250-2000 mg Urolithin A single and repeated dose

Participants

100 healthy adults

Duration

28 days

Results

Dose-dependent absorption with plasma levels peaking at 4-6 hours. No adverse effects up to 2000 mg. Liver function normal. Tissue distribution confirmed. Safety profile established.

How They Measured It

Plasma UA levels, pharmacokinetics, liver function, safety markers

Read full study

Exercise Performance

5

To evaluate Urolithin A on exercise performance and recovery in trained athletes

2023 48 participants 12 weeks 1000 mg/day Urolithin A
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate Urolithin A on exercise performance and recovery in trained athletes

Dose

1000 mg/day Urolithin A

Participants

48 trained endurance athletes

Duration

12 weeks

Results

Significant improvement in time to exhaustion (p=0.03). Post-exercise recovery markers improved. Mitochondrial respiration in muscle biopsies enhanced. VO2 max trending higher.

How They Measured It

VO2 max, time to exhaustion, post-exercise markers, mitochondrial function

Read full study
6

To summarize clinical evidence for Urolithin A supplementation

2023 ? participants Various Various
Review/Other Mixed

Study Type

Systematic review

Purpose

To summarize clinical evidence for Urolithin A supplementation

Dose

Various

Participants

Systematic review

Duration

Various

Results

Growing evidence for mitochondrial, muscle, and anti-inflammatory benefits. Mitophagy induction as novel anti-aging mechanism. Human evidence still early but promising. Safety well-established. Wider RCTs underway.

How They Measured It

Systematic review of human trials

Read full study

Muscle Performance & Aging

7

To determine whether Urolithin A (Mitopure) improves muscle strength, aerobic endurance, and physical performance via mitophagy activation in middle-aged adults.

2022 03464500 participants 4 months Urolithin A (Mitopure) at two doses for 4 months
Human Study RCT Placebo Positive

Study Type

Randomized, placebo-controlled trial

Purpose

To determine whether Urolithin A (Mitopure) improves muscle strength, aerobic endurance, and physical performance via mitophagy activation in middle-aged adults.

Dose

Urolithin A (Mitopure) at two doses for 4 months

Participants

Middle-aged adults (NCT03464500)

Duration

4 months

Results

Significant improvements in muscle strength (~12%) with Urolithin A. Clinically meaningful improvements in aerobic endurance and physical performance. Reduced plasma acylcarnitines and CRP indicating higher mitochondrial efficiency and reduced inflammation. Increased mitophagy/mitochondrial metabolism proteins in skeletal muscle.

How They Measured It

Muscle strength, VO2 peak, 6-minute walk test, peak power output, plasma acylcarnitines, CRP, mitophagy proteins in skeletal muscle

Read full study

Frequently Asked Questions

Common questions about Urolithin A research

What does the research say about Urolithin A?

There are currently 7 peer-reviewed studies on Urolithin A (Urolithin A), involving 362 total participants. Research covers Cellular health, Muscle strength, Mitochondrial function and 2 more areas. The overall evidence strength is rated as Strong.

How strong is the evidence for Urolithin A?

The evidence is currently rated as "Strong Evidence". This rating is based on study design quality (randomisation, blinding, placebo controls), sample sizes, study types (6 human studies), and reported outcomes.

What health goals has Urolithin A been studied for?

Urolithin A has been researched for: Cellular health, Muscle strength, Mitochondrial function, Longevity, Anti-aging. Each area has its own body of evidence which you can explore in the study breakdowns above.

Are the studies on Urolithin A based on human trials?

Yes, 6 out of 7 studies are human trials. Human trials carry more weight in our evidence scoring system.